Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Verdoia

Showing results (21-30 of 199) with videos related to

Pageof 20
Sort By:
Global Heart|March 28, 2022
Impact of 719Trp>Arg Polymorphism of KIF 6 Gene on Contrast Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary InterventionLucia Barbieri, Monica Verdoia, Harry Suryapranata, et al.
Journal of Clinical Medicine|April 28, 2023
New Insights into Pathophysiology and New Risk Factors for ACSMatteo Nardin, Monica Verdoia, Nicola Laera, et al.
Revista Espanola De Cardiologia (English Ed.)|May 21, 2016
Bivalirudin Versus Unfractionated Heparin in Acute Coronary Syndromes: An Updated Meta-analysis of Randomized TrialsMonica Verdoia, Alon Schaffer, Lucia Barbieri, et al.
Kardiologia Polska|May 13, 2022
Low levels of vitamin D and coronary artery disease: Is it time for therapy?Monica Verdoia, Rocco Gioscia, Matteo Nardin, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 7, 2021
Impact of renin angiotensin system inhibitors on homocysteine levels and platelets reactivity in patients on dual antiplatelet therapyMatteo Nardin, Monica Verdoia, Rocco Gioscia, et al.
Cardiovascular Drugs and Therapy|October 21, 2016
Risk and Benefits of Triple Therapy in Patients Undergoing Coronary Stent Implantation Requiring Oral Anticoagulation: A Meta-Analysis of 16 StudiesLucia Barbieri, Monica Verdoia, Alon Schaffer, et al.
International Journal of Cardiology|May 20, 2018
Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: A meta-analysis of 11 randomized trialsMonica Verdoia, Elvin Khedi, Claudia Ceccon, et al.
Thrombosis Research|December 21, 2020
Impact of uric acid on immature platelet fraction in patients undergoing percutaneous coronary interventionMatteo Nardin, Monica Verdoia, Federica Negro, et al.
Journal of Thrombosis and Thrombolysis|April 6, 2023
Lipoprotein associated- phospholipase A2 in STEMI vs. NSTE-ACS patients: a marker of cardiovascular atherosclerotic risk rather than thrombosisMonica Verdoia, Roberta Rolla, Rocco Gioscia, et al.
European Journal of Preventive Cardiology|November 4, 2015
Contrast volume to creatinine clearance ratio for the prediction of contrast-induced nephropathy in patients undergoing coronary angiography or percutaneous interventionLucia Barbieri, Monica Verdoia, Paolo Marino, et al.
Pageof 20

Showing results (21-30 of 199) with videos related to

Sort By:
Pageof 20
Global Heart|March 28, 2022
Impact of 719Trp>Arg Polymorphism of KIF 6 Gene on Contrast Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary InterventionLucia Barbieri, Monica Verdoia, Harry Suryapranata, et al.
Journal of Clinical Medicine|April 28, 2023
New Insights into Pathophysiology and New Risk Factors for ACSMatteo Nardin, Monica Verdoia, Nicola Laera, et al.
Revista Espanola De Cardiologia (English Ed.)|May 21, 2016
Bivalirudin Versus Unfractionated Heparin in Acute Coronary Syndromes: An Updated Meta-analysis of Randomized TrialsMonica Verdoia, Alon Schaffer, Lucia Barbieri, et al.
Kardiologia Polska|May 13, 2022
Low levels of vitamin D and coronary artery disease: Is it time for therapy?Monica Verdoia, Rocco Gioscia, Matteo Nardin, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 7, 2021
Impact of renin angiotensin system inhibitors on homocysteine levels and platelets reactivity in patients on dual antiplatelet therapyMatteo Nardin, Monica Verdoia, Rocco Gioscia, et al.
Cardiovascular Drugs and Therapy|October 21, 2016
Risk and Benefits of Triple Therapy in Patients Undergoing Coronary Stent Implantation Requiring Oral Anticoagulation: A Meta-Analysis of 16 StudiesLucia Barbieri, Monica Verdoia, Alon Schaffer, et al.
International Journal of Cardiology|May 20, 2018
Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: A meta-analysis of 11 randomized trialsMonica Verdoia, Elvin Khedi, Claudia Ceccon, et al.
Thrombosis Research|December 21, 2020
Impact of uric acid on immature platelet fraction in patients undergoing percutaneous coronary interventionMatteo Nardin, Monica Verdoia, Federica Negro, et al.
Journal of Thrombosis and Thrombolysis|April 6, 2023
Lipoprotein associated- phospholipase A2 in STEMI vs. NSTE-ACS patients: a marker of cardiovascular atherosclerotic risk rather than thrombosisMonica Verdoia, Roberta Rolla, Rocco Gioscia, et al.
European Journal of Preventive Cardiology|November 4, 2015
Contrast volume to creatinine clearance ratio for the prediction of contrast-induced nephropathy in patients undergoing coronary angiography or percutaneous interventionLucia Barbieri, Monica Verdoia, Paolo Marino, et al.
Pageof 20